Article
Advancing Precision Medicine for Prostate Cancer Through Genomics
16 Apr 2013
Abstract excerpt
Prostate cancer is the most common type of cancer in men and the second leading cause of cancer death in men in the United States. The recent surge of high-throughput sequencing of cancer genomes has supported an expanding molecular classification of prostate cancer. Translation of these basic science studies into clinically valuable biomarkers for diagnosis and prognosis and biomarkers that are predictive for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
